BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24324118)

  • 1. Re-irradiation using interstitial brachytherapy increases vaginal mucosal reaction compared to initial brachytherapy in patients with gynecological cancer.
    Yoshida K; Yamazaki H; Nakamura S; Masui K; Kotsuma T; Akiyama H; Tanaka E; Yoshioka Y
    Anticancer Res; 2013 Dec; 33(12):5687-92. PubMed ID: 24324118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients with gynecological cancer: speculation on the relation between pallor reaction and stenosis.
    Yoshida K; Yamazaki H; Nakamura S; Masui K; Kotsuma T; Baek SJ; Akiyama H; Tanaka E; Yoshioka Y
    Anticancer Res; 2013 Sep; 33(9):3963-8. PubMed ID: 24023335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer.
    Yoshida K; Yamazaki H; Nakamura S; Masui K; Kotsuma T; Akiyama H; Tanaka E; Narumi Y; Yoshioka Y
    Anticancer Res; 2014 Aug; 34(8):4433-8. PubMed ID: 25075082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies.
    Murakami N; Kasamatsu T; Sumi M; Yoshimura R; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Itami J
    Radiat Oncol; 2014 Jan; 9():31. PubMed ID: 24456669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Re-irradiation With Single-modality Interstitial Brachytherapy for the Treatment of Recurrent Gynaecological Tumours in the Pelvis: A Multi-institutional Study.
    Raziee H; D'Souza D; Velker V; Barnes E; Taggar A; Mendez L; Leung E
    Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):43-51. PubMed ID: 31402286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
    Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
    Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation.
    Murofushi KN; Tanaka R; Ohkawa A; Numajiri H; Minakami S; Okumura T; Sakurai H
    J Contemp Brachytherapy; 2022 Feb; 14(1):60-65. PubMed ID: 35233236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
    Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
    Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
    Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes and Dosimetric Evaluationof Interstitial Brachytherapyin Gynecological Malignancies.
    V VN; Dharmarajan A; Jones J; Yahiya EKN; Muttath G; Sneha N
    Gulf J Oncolog; 2024 May; 1(45):69-74. PubMed ID: 38774935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer.
    Yoshida K; Yamazaki H; Nakamura S; Masui K; Kotsuma T; Akiyama H; Tanaka E; Yoshikawa N; Uesugi Y; Shimbo T; Narumi Y; Yoshioka Y
    J Gynecol Oncol; 2015 Jul; 26(3):179-84. PubMed ID: 25925294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for venous thromboembolism induced by prolonged bed rest during interstitial brachytherapy for gynecological cancer: a retrospective study.
    Murofushi KN; Tomita T; Ohnishi K; Nakai K; Akiyama A; Saida T; Okumura T; Karasawa K; Satoh T; Sakurai H
    Radiat Oncol; 2021 Jun; 16(1):121. PubMed ID: 34187506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results.
    Morimoto M; Isohashi F; Yoshioka Y; Suzuki O; Seo Y; Ogata T; Akino Y; Koizumi M; Ogawa K
    Int J Clin Oncol; 2014 Apr; 19(2):312-8. PubMed ID: 23728882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol.
    Noyes WR; Bastin K; Edwards SA; Buchler DA; Stitt JA; Thomadsen BR; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1439-43. PubMed ID: 7635785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective analysis of catheter complications for gynecological cancers treated with interstitial brachytherapy in the 3D era.
    Mendez LC; Lang P; Patel C; D'Souza D; Gladwish A; D'Alimonte L; Taggar A; Barnes E; Barbera L; Leung E
    Brachytherapy; 2019; 18(1):44-49. PubMed ID: 30316724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.